Article
Sexual dimorphism in outcomes of non-muscle invasive bladder cancer: a role of CD163+ M2…
medRxiv · 2021 · Chenard, S.; Jackson, C.; Vidotto, T.; Chen, L.; Hardy, C.; Jamaspishvilli, T.; Berman, D. M.; Siemens, D. R.; Koti, M.
Key facts
| Title | Sexual dimorphism in outcomes of non-muscle invasive bladder cancer: a role of CD163+ M2 macrophages, B cells and PD-L1 immune checkpoint. |
|---|---|
| First author | Chenard, S.; Jackson, C.; Vidotto, T.; Chen, L.; Hardy, C.; Jamaspishvilli, T.; Berman, D. M.; Siemens, D. R.; Koti, M. |
| Journal | medRxiv |
| Published | Jan 25, 2021 |
| DOI | 10.1101/2021.01.23.427909 |
| Product codes mentioned | NJT |
At a glance
- None FDA submissions mentioned
- 1–9 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1